SCHEMBL16349602

SCHEMBL16349602

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCN(S(=O)(=O)CC[Si](C)(C)C)C[C@H](NCl)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13685647 0.91 — —
SCHEMBL13685665 0.90 — —
SCHEMBL13685649 0.84 — —
SCHEMBL8289630 0.83 PPIA (0.31) —
SCHEMBL13685576 0.80 BACE1 (0.33) —
SCHEMBL13685725 0.79 — —
SCHEMBL12608386 0.79 — —
SCHEMBL8290345 0.79 — —
SCHEMBL8291430 0.79 — —
SCHEMBL8291490 0.77 PPIA (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
Send feedback